UPSC current affairsAll editions

EdMe Daily

Vector Test SeriesTruly personalised. Every test aims at your weak spots.Adaptive UPSC Prelims tests · real PYQs · daily study planStart free →

Polity & Governance

Corporate Laws (Amendment) Bill 2026: Decriminalization and Regulatory Reforms for Ease of Doing Business

Indian Express - ExplainedPrelims · PolityMains · GS2 Governance

The Corporate Laws (Amendment) Bill, 2026 proposes significant amendments to the Companies Act, 2013 and Limited Liability Partnership Act, 2008 to decriminalize minor offences and streamline regulatory processes, aiming to enhance ease of doing business while facing opposition over concerns of excessive delegation of legislative powers.

  • Corporate Laws (Amendment) Bill, 2026 seeks to amend the Companies Act, 2013 and Limited Liability Partnership Act, 2008 to decriminalize minor offences by replacing criminal penalties with monetary fines, reflecting a shift towards a more business-friendly regulatory environment.
  • The Bill proposes to increase the CSR eligibility threshold from Rs 5 crore to Rs 10 crore net profit, exempt small companies from certain CSR provisions, and extend the transfer period for unspent CSR funds from 30 to 90 days for ongoing projects.
  • Hybrid meetings are formalized, allowing companies to hold Annual General Meetings (AGMs) and Extraordinary General Meetings (EGMs) via video conferencing, with a mandate for at least one physical AGM every three years.

Read the full story →

Polity & GovernanceGS2

International RelationsGS2

US Tariffs on Patented Pharma: Impact on India's Generic Drug Dominance

Hindustan Times - IndiaPrelims · International relationsMains · GS2 International relations

The Trump administration imposed 100% tariffs on patented pharmaceutical imports citing national security concerns, exempting generics—a move that temporarily shields India's $64 billion generic drug exports but signals rising protectionism.